Cidara Therapeutics Files 8-K
| Field | Detail |
|---|---|
| Company | Cidara Therapeutics, Inc. |
| Form Type | 8-K |
| Filed Date | Jun 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, routine-update
TL;DR
Cidara Therapeutics filed an 8-K on 6/24/25, mostly for routine updates.
AI Summary
On June 24, 2025, Cidara Therapeutics, Inc. filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits, with no specific material events detailed in the provided text. The company, formerly known as K2 Therapeutics, Inc., is incorporated in Delaware and headquartered in San Diego, California.
Why It Matters
This filing indicates Cidara Therapeutics is providing updated information to the SEC, which could relate to ongoing business operations or financial reporting requirements.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report without disclosure of significant new material events, suggesting low immediate risk.
Key Numbers
- 001-36912 — SEC File Number (Identifies the company's filing with the SEC)
- 46-1537286 — EIN (Employer Identification Number for tax purposes)
Key Players & Entities
- Cidara Therapeutics, Inc. (company) — Registrant
- K2 Therapeutics, Inc. (company) — Former company name
- June 24, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- San Diego, California (location) — Principal executive offices location
FAQ
What specific 'Other Events' are being reported by Cidara Therapeutics, Inc. in this 8-K filing?
The provided text for the 8-K filing does not specify the details of the 'Other Events' beyond listing it as an item information.
When was Cidara Therapeutics, Inc. formerly known as K2 Therapeutics, Inc. and when did the name change occur?
The filing indicates the former company name was K2 Therapeutics, Inc. and the date of the name change was June 11, 2014.
What is the principal executive office address for Cidara Therapeutics, Inc.?
The principal executive offices are located at 6310 Nancy Ridge Drive, Suite 101, San Diego, California 92121.
What is the SIC code for Cidara Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code for Cidara Therapeutics, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
What is the fiscal year end for Cidara Therapeutics, Inc.?
The fiscal year end for Cidara Therapeutics, Inc. is December 31 (1231).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 25, 2025 regarding Cidara Therapeutics, Inc..